子宮筋腫治療薬市場：薬剤クラス別、タイプ別、流通チャネル別、世界予測、2023-2032年

子宮筋腫治療薬市場規模は、2023-2032年にCAGR 10％で大幅な成長を示すと予想されています。

子宮筋腫の世界の有病率の上昇が、有効な薬物介入に対するニーズの高まりを引き起こしています。

最近では、症状を効果的に管理し、腫瘍サイズを縮小するための先進的な薬物療法の開発と提供が重視されるようになってきています。Office on Women's Healthによると、女性の20％から80％が50歳までに子宮筋腫を発症します。そのため、子宮筋腫に罹患している人々の治療ニーズへの取り組みが重視されるようになり、広範な研究開発努力が行われています。さらに、患者や医療専門家の間で、利用可能な治療オプションに対する認識が高まっていることも、製品需要を後押ししています。

子宮筋腫治療薬業界は、薬剤クラス別、タイプ別、流通チャネル別、地域別に区分されます。

薬剤クラス別では、ゴナドトロピン放出ホルモン拮抗薬セグメントの市場シェアが、2023年から2032年の間にかなりの成長を示すことになっています。これは、ゴナドトロピン放出ホルモン（GnRH）拮抗薬が、実行可能な非侵襲的治療オプションとして利用が拡大していることに起因しています。GnRH拮抗薬は、迅速な症状緩和と多量の月経出血を軽減する能力により、大きな注目を集めつつあります。良好な安全性プロファイルや限定された副作用などの利点が、このセグメントの成長にさらに貢献すると思われます。

子宮筋腫治療薬業界は、病院流通チャネルセグメントから2022年にかなりの収益を上げ、2032年まで堅調な拡大が予測されます。この成長は、効果的な治療と患者の転帰の改善を確実にするための、病院における強固なインフラと患者ケアへの統合的なアプローチに起因しています。低侵襲処置への嗜好の高まりに伴い、病院はまた、効果的な子宮筋腫管理のために高度な医薬品ソリューションを採用するようになってきています。

地域的には、アジア太平洋の子宮筋腫治療薬産業は、ヘルスケアインフラ開発の急増、子宮筋腫に関する意識の高まり、健康状態の有病率の上昇を燃料として、2032年まで顕著な成長率を示すと予測されています。低侵襲手術の採用が増加していることから、この地域では特定のニーズに合わせた新しい医薬品ソリューションのイントロダクションが行われています。

さらに、有効性の向上と副作用の最小化を目指した研究開発が進められていることも、この地域の市場展望を拡大すると思われます。一例を挙げると、日本のキッセイ薬品工業株式会社は2022年7月、子宮筋腫を対象としたGNRH拮抗薬リンザゴリックス（KLH-2109）の国内第3相臨床試験を開始しました。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 子宮筋腫治療薬市場の洞察

• 業界情勢
• 業界への影響要因
  • 促進要因
    • 子宮筋腫の有病率の増加
    • 子宮筋腫女性向けの新薬の開発
    • 子宮筋腫に対する意識の高まり
  • 業界の潜在的リスク＆課題
    • 子宮筋腫治療薬に伴う副作用
• 成長可能性分析
• COVID-19影響分析
• 規制状況
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 競合ポジショニングマトリックス
• 戦略ダッシュボード

第5章 子宮筋腫治療薬市場推定・予測：薬剤クラス別

• 主要動向：薬剤クラス別
• 黄体ホルモン放出子宮内避妊器具（IUD）および避妊薬
• ゴナドトロピン放出ホルモン（GnRH）拮抗薬
• ゴナドトロピン放出ホルモン（GnRH）作動薬
• 非ホルモン薬
• その他

第6章 子宮筋腫治療薬市場推定・予測：タイプ別

• 主要動向：タイプ別
• 粘膜下筋腫
• 硬膜内筋腫
• 漿膜下筋腫
• 有茎性筋腫

第7章 子宮筋腫治療薬市場推定・予測：流通チャネル別

• 主要動向：流通チャネル別
• 小売薬局
• 病院薬局
• その他の流通チャネル

第8章 子宮筋腫治療薬市場推定・予測：地域別

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • スイス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東とアフリカ

第9章 企業プロファイル

• Pfizer, Inc.
• Abbvie, Inc.
• AstraZeneca plc
• Bayer AG
• Myovant Sciences Gmbh
• Ferring B.V.
• Amring Pharmaceuticals Inc.
• Theramex
• Watson Pharma, Inc.

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by drug class (2022)
• TABLE 3 Market revenue, by type (2022)
• TABLE 4 Market revenue, by distribution channel (2022)
• TABLE 5 Market share, by region (2022)
• TABLE 6 Global uterine fibroid treatment drugs market size, by region, 2018 - 2022 (USD Million)
• TABLE 7 Global uterine fibroid treatment drugs market size, by region, 2023 - 2032 (USD Million)
• TABLE 8 Global uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 9 Global uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 10 Global uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 11 Global uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 12 Global uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 13 Global uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 14 Industry impact forces
• TABLE 15 Competitive benchmarking of major market players
• TABLE 16 Competitive positioning matrix: Classification criteria
• TABLE 17 Strategic outlook matrix: Classification criteria
• TABLE 18 Progestin-releasing intrauterine device (IUD)& contraceptives market size, by region, 2018 - 2022 (USD Million)
• TABLE 19 Progestin-releasing intrauterine device (IUD)& contraceptives market size, by region, 2023 - 2032 (USD Million)
• TABLE 20 Gonadotropin-releasing hormone (GnRH) antagonists market size, by region, 2018 - 2022 (USD Million)
• TABLE 21 Gonadotropin-releasing hormone (GnRH) antagonists market size, by region, 2023 - 2032 (USD Million)
• TABLE 22 Gonadotropin-releasing hormone (GnRH) agonists market size, by region, 2018 - 2022 (USD Million)
• TABLE 23 Gonadotropin-releasing hormone (GnRH) agonists market size, by region, 2023 - 2032 (USD Million)
• TABLE 24 Non-hormonal medications market size, by region, 2018 - 2022 (USD Million)
• TABLE 25 Non-hormonal medications market size, by region, 2023 - 2032 (USD Million)
• TABLE 26 Other drug classes market size, by region, 2018 - 2022 (USD Million)
• TABLE 27 Other drug classes market size, by region, 2023 - 2032 (USD Million)
• TABLE 28 Submucosal fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 29 Submucosal fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 30 Intramural fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 31 Intramural fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 32 Subserosal fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 33 Subserosal fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 34 Pedunculated fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 35 Pedunculated fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 36 Retail pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 37 Retail pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 38 Hospital pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 39 Hospital pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 40 Other distribution channels market size, by region, 2018 - 2022 (USD Million)
• TABLE 41 Other distribution channels market size, by region, 2023 - 2032 (USD Million)
• TABLE 42 North America uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 43 North America uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 44 North America uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 45 North America uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 46 North America uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 47 North America uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 48 North America uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 49 North America uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 50 U.S. uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 51 U.S. uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 52 U.S. uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 53 U.S. uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 54 U.S. uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 55 U.S. uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 56 Canada uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 57 Canada uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 58 Canada uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 59 Canada uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 60 Canada uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 61 Canada uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 62 Europe uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 63 Europe uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 64 Europe uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 65 Europe uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 66 Europe uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 67 Europe uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 68 Europe uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 69 Europe uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 70 Germany uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 71 Germany uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 72 Germany uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 73 Germany uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 74 Germany uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 75 Germany uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 76 UK uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 77 UK uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 78 UK uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 79 UK uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 80 UK uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 81 UK uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 82 France uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 83 France uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 84 France uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 85 France uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 86 France uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 87 France uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 88 Spain uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 89 Spain uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 90 Spain uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 91 Spain uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 92 Spain uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 93 Spain uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 94 Italy uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 95 Italy uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 96 Italy uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 97 Italy uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 98 Italy uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 99 Italy uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 100 Switzerland uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 101 Switzerland uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 102 Switzerland uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 103 Switzerland uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 104 Switzerland uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 105 Switzerland uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 106 Rest of Europe uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 107 Rest of Europe uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 108 Rest of Europe uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 109 Rest of Europe uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 110 Rest of Europe uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 111 Rest of Europe uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 112 Asia Pacific uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 113 Asia Pacific uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 114 Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 115 Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 116 Asia Pacific uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 117 Asia Pacific uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 118 Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 119 Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 120 China uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 121 China uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 122 China uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 123 China uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 124 China uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 125 China uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 126 Japan uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 127 Japan uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 128 Japan uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 129 Japan uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 130 Japan uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 131 Japan uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 132 India uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 133 India uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 134 India uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 135 India uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 136 India uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 137 India uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 138 Australia uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 139 Australia uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 140 Australia uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 141 Australia uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 142 Australia uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 143 Australia uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 144 South Korea uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 145 South Korea uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 146 South Korea uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 147 South Korea uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 148 South Korea uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 149 South Korea uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 150 Rest of Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 151 Rest of Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 152 Rest of Asia Pacific uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 153 Rest of Asia Pacific uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 154 Rest of Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 155 Rest of Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 156 Latin America uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 157 Latin America uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 158 Latin America uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 159 Latin America uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 160 Latin America uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 161 Latin America uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 162 Latin America uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 163 Latin America uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 164 Brazil uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 165 Brazil uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 166 Brazil uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 167 Brazil uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 168 Brazil uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 169 Brazil uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 170 Mexico uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 171 Mexico uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 172 Mexico uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 173 Mexico uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 174 Mexico uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 175 Mexico uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 176 Rest of Latin America uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 177 Rest of Latin America uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 178 Rest of Latin America uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 179 Rest of Latin America uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 180 Rest of Latin America uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 181 Rest of Latin America uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 182 Middle East & Africa uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 183 Middle East & Africa uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 184 Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 185 Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 186 Middle East & Africa uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 187 Middle East & Africa uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 188 Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 189 Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 190 South Africa uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 191 South Africa uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 192 South Africa uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 193 South Africa uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 194 South Africa uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 195 South Africa uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 196 Saudi Arabia uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 197 Saudi Arabia uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 198 Saudi Arabia uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 199 Saudi Arabia uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 200 Saudi Arabia uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 201 Saudi Arabia uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 202 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 203 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 204 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 205 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 206 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 207 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Uterine fibroid treatment drugs industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by drug class
• FIG 8 Growth potential analysis, by type
• FIG 9 Growth potential analysis, by distribution channel
• FIG 10 Porter's analysis
• FIG 11 PESTEL analysis
• FIG 12 Company matrix analysis, 2022
• FIG 13 Competitive positioning matrix, 2022
• FIG 14 Strategic dashboard, 2022

Uterine Fibroid Treatment Drugs Market size is set to witness substantial growth at 10% CAGR from 2023-2032. The escalating prevalence of uterine fibroids worldwide is triggering the heightened need for efficacious pharmaceutical interventions.

Of late, there has been growing emphasis on developing and providing advanced drug therapies to effectively manage symptoms and reduce tumor size. According to the Office on Women's Health, between 20% and 80% of women develop fibroids by the age of 50 years. Thus, the higher focus on addressing the therapeutic needs of affected individuals has made way for extensive R&D efforts. Moreover, the surging awareness among patients and healthcare professionals about available treatment options is also bolstering the product demand.

The uterine fibroid treatment drugs industry is segmented into drug class, type, distribution channel, and region.

By drug class, the market share from the gonadotropin-releasing hormone antagonist segment is set to witness considerable growth between 2023 and 2032. This can be attributed to the expanding utilization of gonadotropin-releasing hormone (GnRH) antagonists as viable non-invasive treatment options. With their ability to provide rapid symptomatic relief and alleviate heavy menstrual bleeding, GnRH antagonists are gaining significant prominence. Benefits, such as favorable safety profile and limited side effects will further contribute to the segment growth.

Uterine fibroid treatment drugs industry from the hospital distribution channel segment generated substantial revenue in 2022 and is expected to foresee robust expansion through 2032. The growth can be attributed to the robust infrastructure and integrated approach to patient care in hospitals for ensuring effective treatment and improved patient outcomes. With the growing preference for minimally invasive procedures, hospitals are also increasingly adopting advanced pharmaceutical solutions for effective fibroid management.

Regionally, the Asia Pacific uterine fibroid treatment drugs industry is projected to depict notable growth rate through 2032 fueled by the upsurge in healthcare infrastructure development, increasing awareness about uterine fibroids, and the rising prevalence of the health condition. The growing adoption of minimally invasive procedures has led to the introduction of novel pharmaceutical solutions tailored for specific needs in the region.

Moreover, the ongoing research and development activities aimed at enhancing the efficacy and minimizing adverse effects will augment the regional market outlook. To cite an instance, in July 2022, Japan-based Kissei Pharmaceutical Co., Ltd. began a Japanese Phase III clinical study for the GNRH antagonist linzagolix (KLH-2109) in uterine fibroids.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Secondary
    • 1.6.1.1 Paid sources
    • 1.6.1.2 Public sources
  • 1.6.2 Primary

Chapter 2 Executive Summary

• 2.1 Uterine fibroid treatment drugs industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Region trends
  • 2.1.3 Drug class trends
  • 2.1.4 Type trends
  • 2.1.5 Distribution channel trends

Chapter 3 Uterine Fibroid Treatment Drugs Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of uterine fibroid
    • 3.2.1.2 Development of new drugs for women with uterine fibroids
    • 3.2.1.3 Growing awareness about uterine fibroids
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Adverse effects associated with uterine fibroid treatment drugs
• 3.3 Growth potential analysis
  • 3.3.1 By drug class
  • 3.3.2 By type
  • 3.3.3 By distribution channel
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic dashboard, 2022

Chapter 5 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Drug Class (USD Million)

• 5.1 Key trends, by drug class
• 5.2 Progestin-releasing intrauterine device (IUD) & contraceptives
• 5.3 Gonadotropin-releasing hormone (GnRH) antagonists
• 5.4 Gonadotropin-releasing hormone (GnRH) agonists
• 5.5 Non-hormonal medications
• 5.6 Other drug classes

Chapter 6 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Type (USD Million)

• 6.1 Key trends, by type
• 6.2 Submucosal fibroids
• 6.3 Intramural fibroids
• 6.4 Subserosal fibroids
• 6.5 Pedunculated fibroids

Chapter 7 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Distribution Channel (USD Million)

• 7.1 Key trends, by distribution channel
• 7.2 Retail pharmacies
• 7.3 Hospital pharmacies
• 7.4 Other distribution channels

Chapter 8 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Region (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Switzerland
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Pfizer, Inc.
• 9.2 Abbvie, Inc.
• 9.3 AstraZeneca plc
• 9.4 Bayer AG
• 9.5 Myovant Sciences Gmbh
• 9.6 Ferring B.V.
• 9.7 Amring Pharmaceuticals Inc.
• 9.8 Theramex
• 9.9 Watson Pharma, Inc.